Published in Gene Therapy Weekly, August 4th, 1997
"We show that a GAD [glutamic acid decarboxylase]-expressing transgenic plant, given as a dietary supplement, inhibits the development of diabetes in the non-obese diabetic (NOD) mouse," reported S.-W. Ma of the University of Western Ontario, London, Ontario, Canada, and colleagues ("Transgenic Plants Expressing Autoantigens Fed To Mice To Induce Oral Immune Tolerance," Nature Med, 1997;3(7):793-6).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly